SARS-CoV-2-Induced Immune Dysregulation and Myocardial Injury Risk in China : Insights From the ERS-COVID-19 Study
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2020 |
---|---|
Erschienen: |
2020 |
Enthalten in: |
Zur Gesamtaufnahme - volume:127 |
---|---|
Enthalten in: |
Circulation research - 127(2020), 3 vom: 17. Juli, Seite 397-399 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Li, Dongze [VerfasserIn] |
---|
Links: |
---|
Themen: |
9007-41-4 |
---|
Anmerkungen: |
Date Completed 14.08.2020 Date Revised 18.12.2020 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1161/CIRCRESAHA.120.317070 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM309589363 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM309589363 | ||
003 | DE-627 | ||
005 | 20231225134236.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2020 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1161/CIRCRESAHA.120.317070 |2 doi | |
028 | 5 | 2 | |a pubmed24n1031.xml |
035 | |a (DE-627)NLM309589363 | ||
035 | |a (NLM)32375560 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Li, Dongze |e verfasserin |4 aut | |
245 | 1 | 0 | |a SARS-CoV-2-Induced Immune Dysregulation and Myocardial Injury Risk in China |b Insights From the ERS-COVID-19 Study |
264 | 1 | |c 2020 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 14.08.2020 | ||
500 | |a Date Revised 18.12.2020 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
650 | 4 | |a Letter | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 4 | |a COVID-19 | |
650 | 4 | |a coronavirus | |
650 | 4 | |a mortality | |
650 | 4 | |a myocardial injury | |
650 | 4 | |a pneumonia | |
650 | 7 | |a Biomarkers |2 NLM | |
650 | 7 | |a Complement C3 |2 NLM | |
650 | 7 | |a Complement C4 |2 NLM | |
650 | 7 | |a Immunoglobulins |2 NLM | |
650 | 7 | |a Troponin T |2 NLM | |
650 | 7 | |a C-Reactive Protein |2 NLM | |
650 | 7 | |a 9007-41-4 |2 NLM | |
700 | 1 | |a Chen, You |e verfasserin |4 aut | |
700 | 1 | |a Jia, Yu |e verfasserin |4 aut | |
700 | 1 | |a Tong, Le |e verfasserin |4 aut | |
700 | 1 | |a Tong, Jiale |e verfasserin |4 aut | |
700 | 1 | |a Wang, Wei |e verfasserin |4 aut | |
700 | 1 | |a Liu, Yanmei |e verfasserin |4 aut | |
700 | 1 | |a Wan, Zhi |e verfasserin |4 aut | |
700 | 1 | |a Cao, Yu |e verfasserin |4 aut | |
700 | 1 | |a Zeng, Rui |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Circulation research |d 1953 |g 127(2020), 3 vom: 17. Juli, Seite 397-399 |w (DE-627)NLM000001910 |x 1524-4571 |7 nnns |
773 | 1 | 8 | |g volume:127 |g year:2020 |g number:3 |g day:17 |g month:07 |g pages:397-399 |
856 | 4 | 0 | |u http://dx.doi.org/10.1161/CIRCRESAHA.120.317070 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 127 |j 2020 |e 3 |b 17 |c 07 |h 397-399 |